Restoring America

Conservative values, National renewal

What we know about Ozempic’s cancer risks

Published



After a decade of curvaceousness taking center stage as the body type du jour, thin is officially back in. And unlike previous eras, seizing a ticket to this desired destination has never been easier. Weight loss injections allow the average citizen to achieve their #bodygoals in stealth mode, in a world that is more image-conscious and competitive than ever.

Glucagon-like peptide-1 receptor agonists, better known as GLP-1 agonists or by their respective brand names, such as Ozempic or Wegovy, work by slowing the stomach’s process of emptying, lowering the level of glucose in a person’s blood, and making them feel less hungry. The first GLP-1 drug was approved by the Food and Drug Administration in 2005 to treat type 2 diabetes. Some also help to treat obesity and comorbid medical conditions such as high blood pressure.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.